Biomarin Pharmaceutical (BMRN) Cash from Operations (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded Cash from Operations of $168.11 million in Q2 2026, down 9.3% from $185.27 million a year earlier and down 23.8% from the prior quarter.
Biomarin Pharmaceutical (BMRN) Cash from Operations (2009 - 2026) Analysis & Trends
On a TTM basis, Biomarin Pharmaceutical's Cash from Operations came in at $857.09 million as of Jun 30, 2026, up 11.8% year-over-year; for FY2025, it came in at $827.99 million, up 44.5% from FY2024.
- Annual Cash from Operations has a five-year compound annual growth rate of 57.5% (FY2020 to FY2025).
- Across earlier years, Cash from Operations came in at $572.84 million in FY2024 (+259.7%), $159.26 million in FY2023 (-9.5%), $175.9 million in FY2022 (-42.2%) and $304.54 million in FY2021 (+256.7%).
- Quarterly Cash from Operations has ranged from -$73.93 million in Q1 2023 to $368.69 million in Q3 2025 over the past five years.
- On a year-over-year basis, Cash from Operations rose in six of the last eight quarters, with growth averaging 125.4%.
- Peak year-over-year performance for Cash from Operations in the last five years was growth of 575.4% in Q4 2024, against a decline of 46.3% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $220.65 million (Q1 2026), $99.64 million (Q4 2025) and $368.69 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | 168.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 168.11 Mn |
| Mar 31, 2026 | 220.65 Mn |
| Dec 31, 2025 | 99.64 Mn |
| Sep 30, 2025 | 368.69 Mn |
| Jun 30, 2025 | 185.27 Mn |
| Mar 31, 2025 | 174.39 Mn |
| Dec 31, 2024 | 185.63 Mn |
| Sep 30, 2024 | 221.48 Mn |
| Jun 30, 2024 | 118.76 Mn |
| Mar 31, 2024 | 46.97 Mn |
| Dec 31, 2023 | 27.48 Mn |
| Sep 30, 2023 | 135.65 Mn |
| Jun 30, 2023 | 70.06 Mn |
| Mar 31, 2023 | -73.93 Mn |
| Dec 31, 2022 | 6.79 Mn |
| Sep 30, 2022 | 158.32 Mn |
| Jun 30, 2022 | 56.23 Mn |
| Mar 31, 2022 | -45.43 Mn |
| Dec 31, 2021 | 11.18 Mn |
| Sep 30, 2021 | 97.06 Mn |
Biomarin Pharmaceutical Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();